GeneBioHealth
Latest round
- Series B
Last raised
- Oct 2022
Total raised
- $15M
Investors
- 1
About GeneBioHealth
Based in Shenzhen, China and founded in 2013, GeneBioHealth operates as a diagnostic reagent developer that focuses on in vitro diagnostics (IVD) and healthcare. The company headquarter in Shenzhen has 1500 square meters. And has over 500 square meters of GMP standard workshop., Ltd. In January 2017, GeneBioHealth passed the ISO13485 certification. In March 2018, GeneBioHealth's product - Ruichangtai ® MiR-92a test kit was approved for listing. Its products include tumor diagnosis, Covid-19 protection, immunodiagnosis (POCT) and instrument. Covid-19 protection includes SARS-CoV-2 IgM/IgG test kit(colloidal gold), SARS-COV-2 nucleic acid test kit (RT-PCR) and Baihuikang hypochlorous acid disinfectant. POCT includes the testing of cardiovascular, inflammatory and digestive function. The company's services include detection of tumor, membership service, detection report and health file.
Who invested in GeneBioHealth
1 investor across 1 round
See all investors in GeneBioHealth
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 18, 2022
Amount
$15M
Investors
Questions about GeneBioHealth
Who invested in GeneBioHealth?
GeneBioHealth has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GeneBioHealth raised?
GeneBioHealth has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did GeneBioHealth last raise money?
GeneBioHealth's most recent round on record is a Series B, in Oct 2022.
What does GeneBioHealth do?
Based in Shenzhen, China and founded in 2013, GeneBioHealth operates as a diagnostic reagent developer that focuses on in vitro diagnostics (IVD) and healthcare.
Where is GeneBioHealth headquartered?
GeneBioHealth is headquartered in Shenzhen, China.
Which VCs invest in companies like GeneBioHealth?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at GeneBioHealth's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like GeneBioHealth? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.